- Home
- IVR vs LRMR Comparison
IVR vs LRMR Comparison
Compare IVR & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVR
- LRMR
- Stock Information
- Founded
- IVR 2008
- LRMR N/A
- Country
- IVR United States
- LRMR United States
- Employees
- IVR N/A
- LRMR N/A
- Industry
- IVR Real Estate Investment Trusts
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- IVR Real Estate
- LRMR Health Care
- Exchange
- IVR Nasdaq
- LRMR Nasdaq
- Market Cap
- IVR 493.1M
- LRMR 426.9M
- IPO Year
- IVR 2009
- LRMR N/A
- Fundamental
- Price
- IVR $8.56
- LRMR $3.75
- Analyst Decision
- IVR Buy
- LRMR Strong Buy
- Analyst Count
- IVR 3
- LRMR 9
- Target Price
- IVR N/A
- LRMR $19.44
- AVG Volume (30 Days)
- IVR 1.2M
- LRMR 572.0K
- Earning Date
- IVR 02-20-2025
- LRMR 03-13-2025
- Dividend Yield
- IVR 18.96%
- LRMR N/A
- EPS Growth
- IVR N/A
- LRMR N/A
- EPS
- IVR 1.23
- LRMR N/A
- Revenue
- IVR $102,893,000.00
- LRMR N/A
- Revenue This Year
- IVR N/A
- LRMR N/A
- Revenue Next Year
- IVR $8.53
- LRMR N/A
- P/E Ratio
- IVR $6.93
- LRMR N/A
- Revenue Growth
- IVR 654.96
- LRMR N/A
- 52 Week Low
- IVR $7.48
- LRMR $3.01
- 52 Week High
- IVR $9.97
- LRMR $13.68
- Technical
- Relative Strength Index (RSI)
- IVR 61.69
- LRMR 43.71
- Support Level
- IVR $8.10
- LRMR $3.54
- Resistance Level
- IVR $8.53
- LRMR $4.24
- Average True Range (ATR)
- IVR 0.16
- LRMR 0.25
- MACD
- IVR 0.06
- LRMR 0.11
- Stochastic Oscillator
- IVR 97.64
- LRMR 44.66
About IVR INVESCO MORTGAGE CAPITAL INC
Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.